Literature DB >> 15566939

Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV.

Hiroyuki Iwahana1, Morisada Hayakawa, Kenji Kuroiwa, Kenji Tago, Ken Yanagisawa, Sumihare Noji, Shin-ichi Tominaga.   

Abstract

The ST2 gene encodes receptor-like molecules that are very similar to the interleukin-1 receptors. Three types of ST2 gene products, ST2, ST2L, and ST2V, can be produced by alternative splicing. In the course of cloning the chicken ST2 and ST2L cDNAs, we identified a novel variant cDNA other than ST2, ST2L, or ST2V, and tentatively named it ST2LV. ST2LV was produced by alternative splicing that deleted the transmembrane domain of ST2L. The chicken ST2 gene consisted of 13 exons and had two promoters followed by noncoding exons 1a and 1b, like the ST2 genes of human, mouse, and rat. The chicken ST2 mRNA was detected by RT-PCR as early as embryonic day 5. After that, the chicken ST2 mRNA was expressed in all examined organs, including the brain, eye, heart, lung, and liver. The chicken ST2LV mRNA was detected from embryonic day 10. The chicken ST2LV cDNA was transiently expressed in COS-7 cells. A protein of 69 kDa was detected in the culture supernatant, and the size of the protein was reduced to 53 kDa by treatment with peptide-N-glycosidase F, which suggested that ST2LV is a new soluble secreted and N-glycosylated variant of the ST2 gene product.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566939     DOI: 10.1016/j.bbaexp.2004.08.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Evolutionary conservation of alternative splicing in chicken.

Authors:  S Katyal; Z Gao; R-Z Liu; R Godbout
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

2.  ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells.

Authors:  Shinsuke Aoki; Morisada Hayakawa; Hiromi Ozaki; Naoki Takezako; Hiroto Obata; Nobuhiro Ibaraki; Tadahiko Tsuru; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

3.  Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists.

Authors:  Swamy Kumar Polumuri; Gift Gunaraj Jayakar; Kari Ann Shirey; Zachary J Roberts; Darren J Perkins; Paula M Pitha; Stefanie N Vogel
Journal:  J Immunol       Date:  2012-05-25       Impact factor: 5.422

Review 4.  IL-33 and the intestine: The good, the bad, and the inflammatory.

Authors:  Zerina Hodzic; Ellen Merrick Schill; Alexa M Bolock; Misty Good
Journal:  Cytokine       Date:  2017-07-04       Impact factor: 3.861

Review 5.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

Review 6.  The chicken IL-1 family: evolution in the context of the studied vertebrate lineage.

Authors:  Mark S Gibson; Pete Kaiser; Mark Fife
Journal:  Immunogenetics       Date:  2014-05-27       Impact factor: 2.846

7.  Runx2 mediated Induction of Novel Targets ST2 and Runx3 Leads to Cooperative Regulation of Hypertrophic Differentiation in ATDC5 Chondrocytes.

Authors:  Ehsan Bonyadi Rad; Giuseppe Musumeci; Karin Pichler; Maryam Heidary; Marta Anna Szychlinska; Paola Castrogiovanni; Egon Marth; Christina Böhm; Sriveena Srinivasaiah; Gerhard Krönke; Annelie Weinberg; Ute Schäfer
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

Review 8.  The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.

Authors:  Brad Griesenauer; Sophie Paczesny
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

Review 9.  Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.

Authors:  Yun Sun; Yankai Wen; Luxi Wang; Liang Wen; Wendong You; Shuang Wei; Lin Mao; Hao Wang; Zuobing Chen; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa.

Authors:  Marina García-Miguel; M Julieta González; Rodrigo Quera; Marcela A Hermoso
Journal:  Biomed Res Int       Date:  2012-12-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.